Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001157523-10-001588
Filing Date
2010-03-16
Accepted
2010-03-16 12:32:49
Documents
13
Period of Report
2009-07-31

Document Format Files

Seq Description Document Type Size
1 LIGHTLAKE THERAPEUTICS INC. 10-K a6213093.htm 10-K/A 512460
2 EXHIBIT 3(I) a6213093ex3i.htm EX-3.I 40766
3 EXHIBIT 10.4 a6213093ex10_4.htm EX-10.4 63875
4 EXHIBIT 10.5 a6213093ex10_5.htm EX-10.5 102633
5 EXHIBIT 10.6 a6213093ex10_6.htm EX-10.6 122708
6 EXHIBIT 10.7 a6213093ex10_7.htm EX-10.7 314173
7 EXHIBIT 31.1 a6213093ex31_1.htm EX-31.1 14490
8 EXHIBIT 31.2 a6213093ex31_2.htm EX-31.2 14489
9 EXHIBIT 32 a6213093ex32.htm EX-32 8411
10 GRAPHIC cpa.jpg GRAPHIC 2354
11 GRAPHIC exhibit3seal.jpg GRAPHIC 124760
12 GRAPHIC exhibit3articles.jpg GRAPHIC 122320
13 GRAPHIC fig10-6.jpg GRAPHIC 74882
  Complete submission text file 0001157523-10-001588.txt   1642921
Mailing Address 225-230 QUEENS QUAY W. TORONTO A6 M5J 2Y7
Business Address 225-230 QUEENS QUAY W. TORONTO A6 M5J 2Y7 416-841-5414
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-K/A | Act: 34 | File No.: 333-139915 | Film No.: 10684515
SIC: 1000 Metal Mining